Ximelagatran and melagatran vs. low-molecular-weight heparin in major orthopedic surgery: relationship between efficacy and safety and timing of initial administration.

P. Zufferey (1) , S. Laporte (1) , S. Molliex , C. Auboyer , P. Mismetti (1)

1 GRT - Groupe de recherche sur la thrombose, pharmacologie des antithrombotiques et situations à risque

Domaines: Pharmacologie

P. Zufferey, S. Laporte, S. Molliex, C. Auboyer, P. Mismetti. Ximelagatran and melagatran vs. low-molecular-weight heparin in major orthopedic surgery: relationship between efficacy and safety and timing of initial administration.. Journal of Thrombosis and Haemostasis, 2005, 3 (5), pp.1104-7. ⟨10.1111/j.1538-7836.2005.01318.x⟩. ⟨ujm-00439804⟩